SIM
CINC

Sandia Investment Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Sandia Investment Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,800
Closed -$59K – 297
2022
Q4 		$59K Sell
4,800
-200
-4% -$4.77K 0.01% 187
2022
Q3 		$164K Buy
+5,000
New +$141K 0.02% 177

Sandia Investment Management's CINC Position: Q1 2023 in Review

Sandia Investment Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 4,800 shares — an estimated $59K sold.

Sandia Investment Management first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $164K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Sandia Investment Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Sandia Investment Management sold 4,800 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $59K.
  • Sandia Investment Management first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Sandia Investment Management's CinCor Pharma, Inc. Common Stock position peaked at $164K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Sandia Investment Management's 13F filing for Q1 2023, filed 15 May 2023.